| Dr Joel Edward Cleary, MD, MHA | |
|
607 W Main St, Grangeville, ID 83530-1345 | |
| (208) 983-8590 | |
| (208) 983-8580 |
| Full Name | Dr Joel Edward Cleary |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 607 W Main St, Grangeville, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417960709 | NPI | - | NPPES |
| Entity Name | Tuba City Regional Health Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548294424 PECOS PAC ID: 4284542531 Enrollment ID: O20031105000107 |
News Archive
Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.
Miami's St. Thomas University is addressing critical employment needs from recent high school graduates, South Florida's emerging Latino population, and those looking for second careers that can be launched within less than a year. A new Pharmacy Technician training course has been developed by former University of Florida Dean of Pharmacy Dr. William Riffee, offering a quick option to enter a rapidly growing occupational field.
Loyola University Health Systems (LUHS) has received a $1.6 million contract from the U.S. Department of Defense (DOD) to research burn injuries, the care of burn wounds and infections and how burns affect the immune system.
Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, shows that eating a junk-food diet during pregnancy changes the development of the opioid signalling pathway in the baby's brain and permanently alters the way this system operates after birth.
› Verified 7 days ago
| Entity Name | Dhhs,phs,naihs, Gallup Indian Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225002322 PECOS PAC ID: 3173436409 Enrollment ID: O20031111000840 |
News Archive
Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.
Miami's St. Thomas University is addressing critical employment needs from recent high school graduates, South Florida's emerging Latino population, and those looking for second careers that can be launched within less than a year. A new Pharmacy Technician training course has been developed by former University of Florida Dean of Pharmacy Dr. William Riffee, offering a quick option to enter a rapidly growing occupational field.
Loyola University Health Systems (LUHS) has received a $1.6 million contract from the U.S. Department of Defense (DOD) to research burn injuries, the care of burn wounds and infections and how burns affect the immune system.
Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, shows that eating a junk-food diet during pregnancy changes the development of the opioid signalling pathway in the baby's brain and permanently alters the way this system operates after birth.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joel Edward Cleary, MD, MHA 607 W Main St, Grangeville, ID 83530-1345 Ph: (208) 983-8590 | Dr Joel Edward Cleary, MD, MHA 607 W Main St, Grangeville, ID 83530-1345 Ph: (208) 983-8590 |
News Archive
Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.
Miami's St. Thomas University is addressing critical employment needs from recent high school graduates, South Florida's emerging Latino population, and those looking for second careers that can be launched within less than a year. A new Pharmacy Technician training course has been developed by former University of Florida Dean of Pharmacy Dr. William Riffee, offering a quick option to enter a rapidly growing occupational field.
Loyola University Health Systems (LUHS) has received a $1.6 million contract from the U.S. Department of Defense (DOD) to research burn injuries, the care of burn wounds and infections and how burns affect the immune system.
Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, shows that eating a junk-food diet during pregnancy changes the development of the opioid signalling pathway in the baby's brain and permanently alters the way this system operates after birth.
› Verified 7 days ago